Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II)
BackgroundWe conducted a pilot 2-arm randomized controlled trial to assess the feasibility of a digital health intervention to increase moderate-to-vigorous physical activity in patients with colorectal cancer (CRC) during chemotherapy. ObjectiveThis study aimed t...
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JMIR Publications
2022-01-01
|
| Series: | JMIR Cancer |
| Online Access: | https://cancer.jmir.org/2022/1/e31576 |
| _version_ | 1797735392921780224 |
|---|---|
| author | Erin L Van Blarigan Anand Dhruva Chloe E Atreya Stacey A Kenfield June M Chan Alexandra Milloy Iris Kim Paige Steiding Angela Laffan Li Zhang Sorbarikor Piawah Yoshimi Fukuoka Christine Miaskowski Frederick M Hecht Mi-Ok Kim Alan P Venook Katherine Van Loon |
| author_facet | Erin L Van Blarigan Anand Dhruva Chloe E Atreya Stacey A Kenfield June M Chan Alexandra Milloy Iris Kim Paige Steiding Angela Laffan Li Zhang Sorbarikor Piawah Yoshimi Fukuoka Christine Miaskowski Frederick M Hecht Mi-Ok Kim Alan P Venook Katherine Van Loon |
| author_sort | Erin L Van Blarigan |
| collection | DOAJ |
| description |
BackgroundWe conducted a pilot 2-arm randomized controlled trial to assess the feasibility of a digital health intervention to increase moderate-to-vigorous physical activity in patients with colorectal cancer (CRC) during chemotherapy.
ObjectiveThis study aimed to determine whether a digital health physical activity intervention is feasible and acceptable during chemotherapy for CRC.
MethodsPotentially eligible patients with CRC expected to receive at least 12 weeks of chemotherapy were identified in person at the University of California, San Francisco, and on the web through advertising. Eligible patients were randomized 1:1 to a 12-week intervention (Fitbit Flex, automated SMS text messages) versus usual care. At 0 and 12 weeks, patients wore an Actigraph GT3X+ accelerometer for 7 days and completed surveys, body size measurements, and an optional 6-minute walk test. Participants could not be masked to their intervention arm, but people assessing the body size and 6-minute walk test outcomes were masked. The primary outcomes were adherence (eg, Fitbit wear and text response rate) and self-assessed acceptability of the intervention. The intervention would be considered feasible if we observed at least 80% complete follow-up and 70% adherence and satisfaction, a priori.
ResultsFrom 2018 to 2020, we screened 240 patients; 53.3% (128/240) of patients were ineligible and 26.7% (64/240) declined to participate. A total of 44 patients (44/240, 18%) were randomized to the intervention (n=22) or control (n=22) groups. Of these, 57% (25/44) were women; 68% (30/44) identified as White and 25% (11/44) identified as Asian American or Pacific Islander; and 77% (34/44) had a 4-year college degree. The median age at enrollment was 54 years (IQR 45-62 years). Follow-up at 12 weeks was 91% (40/44) complete. In the intervention arm, patients wore Fitbit devices on a median of 67 out of 84 (80%) study days and responded to a median of 17 out of 27 (63%) questions sent via SMS text message. Among 19 out of 22 (86%) intervention patients who completed the feedback survey, 89% (17/19) were satisfied with the Fitbit device; 63% (12/19) were satisfied with the SMS text messages; 68% (13/19) said the SMS text messages motivated them to exercise; 74% (14/19) said the frequency of SMS text messages (1-3 days) was ideal; and 79% (15/19) said that receiving SMS text messages in the morning and evening was ideal.
ConclusionsThis pilot study demonstrated that many people receiving chemotherapy for CRC are interested in participating in digital health physical activity interventions. Fitbit adherence was high; however, participants indicated a desire for more tailored SMS text message content. Studies with more socioeconomically diverse patients with CRC are required.
Trial RegistrationClinicalTrials.gov NCT03524716; https://clinicaltrials.gov/ct2/show/NCT03524716 |
| first_indexed | 2024-03-12T12:58:22Z |
| format | Article |
| id | doaj.art-50ced8a496b643e2afe499c4101d7b48 |
| institution | Directory Open Access Journal |
| issn | 2369-1999 |
| language | English |
| last_indexed | 2024-03-12T12:58:22Z |
| publishDate | 2022-01-01 |
| publisher | JMIR Publications |
| record_format | Article |
| series | JMIR Cancer |
| spelling | doaj.art-50ced8a496b643e2afe499c4101d7b482023-08-28T20:20:09ZengJMIR PublicationsJMIR Cancer2369-19992022-01-0181e3157610.2196/31576Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II)Erin L Van Blariganhttps://orcid.org/0000-0001-5079-3385Anand Dhruvahttps://orcid.org/0000-0001-5552-7131Chloe E Atreyahttps://orcid.org/0000-0003-2954-1727Stacey A Kenfieldhttps://orcid.org/0000-0002-1585-7352June M Chanhttps://orcid.org/0000-0002-7620-569XAlexandra Milloyhttps://orcid.org/0000-0002-9085-9112Iris Kimhttps://orcid.org/0000-0001-7023-2411Paige Steidinghttps://orcid.org/0000-0002-5938-9896Angela Laffanhttps://orcid.org/0000-0003-1180-1893Li Zhanghttps://orcid.org/0000-0001-9242-0763Sorbarikor Piawahhttps://orcid.org/0000-0002-1655-6113Yoshimi Fukuokahttps://orcid.org/0000-0002-2245-9264Christine Miaskowskihttps://orcid.org/0000-0001-5170-2027Frederick M Hechthttps://orcid.org/0000-0002-5782-1171Mi-Ok Kimhttps://orcid.org/0000-0002-7712-3653Alan P Venookhttps://orcid.org/0000-0001-9749-6548Katherine Van Loonhttps://orcid.org/0000-0002-9705-4114 BackgroundWe conducted a pilot 2-arm randomized controlled trial to assess the feasibility of a digital health intervention to increase moderate-to-vigorous physical activity in patients with colorectal cancer (CRC) during chemotherapy. ObjectiveThis study aimed to determine whether a digital health physical activity intervention is feasible and acceptable during chemotherapy for CRC. MethodsPotentially eligible patients with CRC expected to receive at least 12 weeks of chemotherapy were identified in person at the University of California, San Francisco, and on the web through advertising. Eligible patients were randomized 1:1 to a 12-week intervention (Fitbit Flex, automated SMS text messages) versus usual care. At 0 and 12 weeks, patients wore an Actigraph GT3X+ accelerometer for 7 days and completed surveys, body size measurements, and an optional 6-minute walk test. Participants could not be masked to their intervention arm, but people assessing the body size and 6-minute walk test outcomes were masked. The primary outcomes were adherence (eg, Fitbit wear and text response rate) and self-assessed acceptability of the intervention. The intervention would be considered feasible if we observed at least 80% complete follow-up and 70% adherence and satisfaction, a priori. ResultsFrom 2018 to 2020, we screened 240 patients; 53.3% (128/240) of patients were ineligible and 26.7% (64/240) declined to participate. A total of 44 patients (44/240, 18%) were randomized to the intervention (n=22) or control (n=22) groups. Of these, 57% (25/44) were women; 68% (30/44) identified as White and 25% (11/44) identified as Asian American or Pacific Islander; and 77% (34/44) had a 4-year college degree. The median age at enrollment was 54 years (IQR 45-62 years). Follow-up at 12 weeks was 91% (40/44) complete. In the intervention arm, patients wore Fitbit devices on a median of 67 out of 84 (80%) study days and responded to a median of 17 out of 27 (63%) questions sent via SMS text message. Among 19 out of 22 (86%) intervention patients who completed the feedback survey, 89% (17/19) were satisfied with the Fitbit device; 63% (12/19) were satisfied with the SMS text messages; 68% (13/19) said the SMS text messages motivated them to exercise; 74% (14/19) said the frequency of SMS text messages (1-3 days) was ideal; and 79% (15/19) said that receiving SMS text messages in the morning and evening was ideal. ConclusionsThis pilot study demonstrated that many people receiving chemotherapy for CRC are interested in participating in digital health physical activity interventions. Fitbit adherence was high; however, participants indicated a desire for more tailored SMS text message content. Studies with more socioeconomically diverse patients with CRC are required. Trial RegistrationClinicalTrials.gov NCT03524716; https://clinicaltrials.gov/ct2/show/NCT03524716https://cancer.jmir.org/2022/1/e31576 |
| spellingShingle | Erin L Van Blarigan Anand Dhruva Chloe E Atreya Stacey A Kenfield June M Chan Alexandra Milloy Iris Kim Paige Steiding Angela Laffan Li Zhang Sorbarikor Piawah Yoshimi Fukuoka Christine Miaskowski Frederick M Hecht Mi-Ok Kim Alan P Venook Katherine Van Loon Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II) JMIR Cancer |
| title | Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II) |
| title_full | Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II) |
| title_fullStr | Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II) |
| title_full_unstemmed | Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II) |
| title_short | Feasibility and Acceptability of a Physical Activity Tracker and Text Messages to Promote Physical Activity During Chemotherapy for Colorectal Cancer: Pilot Randomized Controlled Trial (Smart Pace II) |
| title_sort | feasibility and acceptability of a physical activity tracker and text messages to promote physical activity during chemotherapy for colorectal cancer pilot randomized controlled trial smart pace ii |
| url | https://cancer.jmir.org/2022/1/e31576 |
| work_keys_str_mv | AT erinlvanblarigan feasibilityandacceptabilityofaphysicalactivitytrackerandtextmessagestopromotephysicalactivityduringchemotherapyforcolorectalcancerpilotrandomizedcontrolledtrialsmartpaceii AT ananddhruva feasibilityandacceptabilityofaphysicalactivitytrackerandtextmessagestopromotephysicalactivityduringchemotherapyforcolorectalcancerpilotrandomizedcontrolledtrialsmartpaceii AT chloeeatreya feasibilityandacceptabilityofaphysicalactivitytrackerandtextmessagestopromotephysicalactivityduringchemotherapyforcolorectalcancerpilotrandomizedcontrolledtrialsmartpaceii AT staceyakenfield feasibilityandacceptabilityofaphysicalactivitytrackerandtextmessagestopromotephysicalactivityduringchemotherapyforcolorectalcancerpilotrandomizedcontrolledtrialsmartpaceii AT junemchan feasibilityandacceptabilityofaphysicalactivitytrackerandtextmessagestopromotephysicalactivityduringchemotherapyforcolorectalcancerpilotrandomizedcontrolledtrialsmartpaceii AT alexandramilloy feasibilityandacceptabilityofaphysicalactivitytrackerandtextmessagestopromotephysicalactivityduringchemotherapyforcolorectalcancerpilotrandomizedcontrolledtrialsmartpaceii AT iriskim feasibilityandacceptabilityofaphysicalactivitytrackerandtextmessagestopromotephysicalactivityduringchemotherapyforcolorectalcancerpilotrandomizedcontrolledtrialsmartpaceii AT paigesteiding feasibilityandacceptabilityofaphysicalactivitytrackerandtextmessagestopromotephysicalactivityduringchemotherapyforcolorectalcancerpilotrandomizedcontrolledtrialsmartpaceii AT angelalaffan feasibilityandacceptabilityofaphysicalactivitytrackerandtextmessagestopromotephysicalactivityduringchemotherapyforcolorectalcancerpilotrandomizedcontrolledtrialsmartpaceii AT lizhang feasibilityandacceptabilityofaphysicalactivitytrackerandtextmessagestopromotephysicalactivityduringchemotherapyforcolorectalcancerpilotrandomizedcontrolledtrialsmartpaceii AT sorbarikorpiawah feasibilityandacceptabilityofaphysicalactivitytrackerandtextmessagestopromotephysicalactivityduringchemotherapyforcolorectalcancerpilotrandomizedcontrolledtrialsmartpaceii AT yoshimifukuoka feasibilityandacceptabilityofaphysicalactivitytrackerandtextmessagestopromotephysicalactivityduringchemotherapyforcolorectalcancerpilotrandomizedcontrolledtrialsmartpaceii AT christinemiaskowski feasibilityandacceptabilityofaphysicalactivitytrackerandtextmessagestopromotephysicalactivityduringchemotherapyforcolorectalcancerpilotrandomizedcontrolledtrialsmartpaceii AT frederickmhecht feasibilityandacceptabilityofaphysicalactivitytrackerandtextmessagestopromotephysicalactivityduringchemotherapyforcolorectalcancerpilotrandomizedcontrolledtrialsmartpaceii AT miokkim feasibilityandacceptabilityofaphysicalactivitytrackerandtextmessagestopromotephysicalactivityduringchemotherapyforcolorectalcancerpilotrandomizedcontrolledtrialsmartpaceii AT alanpvenook feasibilityandacceptabilityofaphysicalactivitytrackerandtextmessagestopromotephysicalactivityduringchemotherapyforcolorectalcancerpilotrandomizedcontrolledtrialsmartpaceii AT katherinevanloon feasibilityandacceptabilityofaphysicalactivitytrackerandtextmessagestopromotephysicalactivityduringchemotherapyforcolorectalcancerpilotrandomizedcontrolledtrialsmartpaceii |